The adverse effects of maternal diabetes on embryo development and pregnancy outcomes have recently been shown to occur as early as the one-cell zygote stage. The hypothesis of this study was that maternally inherited mitochondria in oocytes from diabetic mice are abnormal and thus responsible in part for this latency of developmental compromise. In ovulated oocytes from diabetic mice, transmission electron microscopy revealed an alteration in mitochondrial ultrastructure, and the quantitative analysis of mitochondrial DNA copy number demonstrated an increase. The levels of ATP and tricarboxylic acid cycle metabolites in diabetic oocytes were markedly reduced compared with controls, suggesting a mitochondrial metabolic dysfunction. Abnormal distribution of mitochondria within maturing oocytes also was seen in diabetic mice. Furthermore, oocytes from diabetic mice displayed a higher frequency of spindle defects and chromosome misalignment in meiosis, resulting in increased aneuploidy rates in ovulated oocytes. Collectively, our results suggest that maternal diabetes results in oocyte defects that are transmitted to the fetus by two routes: first, meiotic spindle and chromatin defects result in nondisjunction leading to embryonic aneuploidy; second, structural and functional abnormalities of oocyte mitochondria, through maternal transmission, provide the embryo with a dysfunctional complement of mitochondria that may be propagated during embryogenesis.
W
omen with poorly controlled type I diabetes often suffer from reproductive problems, such as miscarriage and offspring with congenital malformations (1) . Likewise, numerous reports have suggested that the diabetic condition adversely affects the development of preand postimplantation embryos in rodents (2) (3) (4) (5) . Earlier studies showed that in vitro-cultured two-cell embryos that were recovered from diabetic mice still experience significant delay in their progression to the blastocyst stage (2). Veselá et al. (6) also observed that about 50% of two-cell embryos isolated from subdiabetic rats were unable to develop to the eight-cell stage, even in a nondiabetic tract. Most recently, we reported that one-cell zygote transfer from diabetic to nondiabetic mouse results in congenital malformations and growth retardation in the offspring (5) . Meanwhile, it has been widely reported that preovulatory oocytes from chemically induced diabetic mice experience delayed germinal vesicle (GV) breakdown and abnormal cellular metabolism (2, (7) (8) (9) (10) . Given the above findings, it is attractive to hypothesize that maternal diabetes has detrimental effects as early as the oocyte stage, which may further predispose to postfertilization developmental abnormalities and even metabolic diseases in the offspring (8, 11) . To date, however, the effects of maternal diabetes on the oocyte and meiotic events remains poorly understood at cellular and molecular levels.
Mitochondria have profound influences on the quality of the mammalian oocyte. Mitochondrial redistribution and metabolic activity and mitochondrial DNA (mtDNA) copy number and mutations have been suggested as the indicators of oocyte competence and are strongly linked with fertilization rates, embryo development, and mater-nal age (12) . On the one hand, maternal transmission of mitochondria with mutations in their genome is the genetic basis for the inheritance of certain debilitating or ultimately lethal metabolic disorders in the human (13) . On the other hand, many aspects of mitochondrial bioenergetics and function are altered in various tissues from diabetes models (14) . Our previous research also showed that early embryos exposed to elevated glucose conditions experienced higher tricarboxylic acid (TCA) metabolites, suggesting alterations in mitochondrial physiology (15) . Thus, investigation of mitochondrial status in oocytes from diabetic mice may inform us on the origin of reproductive failure in diabetic females.
The processes of spindle formation and chromatin organization are believed to be particularly sensitive to physical, chemical, and endocrine environments (16) . Abnormalities in the meiotic spindle and chromosome alignment are known to result in improper chromosome segregation and nondisjunction of the chromatids at the first or second meiotic division, contributing to an increased incidence of aneuploidy (17) . Notably, several lines of evidence have suggested that the structure and function of microtubules were altered in some tissues from diabetic models (18, 19) . Recently, a few factors associated with mitochondrial metabolism, such as ATP, reactive oxygen species, and pyruvate dehydrogenase complex, have been demonstrated to be required for proper spindle assembly and chromosome alignment in oocyte meiosis (20 -22) . It should be noted that we detected diminished ATP levels in preovulatory oocytes from diabetic mice (9, 10) . Together, these findings prompted us to investigate the effect of maternal diabetes on spindle and chromosome alignment in oocytes.
To address above questions, we used a streptozotocin (STZ)-induced diabetic mouse model to investigate the effects of maternal diabetes on the mitochondrial status and spindle and chromosome organization in oocytes. We also confirmed key findings using the Akita genetic mouse model as a control for the STZ-induced effects. By performing molecular, cellular, and biochemical analysis, we show here that maternal diabetes results in structural and spatial dysfunction of mitochondria and induces spindle defects and chromosome misalignment in oocytes, which may be manifested later as developmental abnormalities in preimplantation embryos, congenital malformations, and even metabolic disease in the offspring.
Results

Morphological evaluation of ovulated oocytes from diabetic mice
Morphological parameters have been widely recognized an as indicator of oocyte quality (12) . To examine the potential effects of maternal diabetes on the oocyte phenotype, ovulated metaphase II (MII) oocytes were recovered ( Fig. 1) and then examined by stereomicroscopy and scored for morphological abnormalities. We found that 11.2% of oocytes (n ϭ 170) from diabetic mice showed abnormal morphological characteristics ( Fig. 2A , black arrowheads), including 1) enlarged perivitelline space, 2) giant polar bodies, and 3) fragmented cytoplasm, and which were found to be significantly higher than controls (3.3%, n ϭ 152; Fig. 2B ). Given the direct support of the follicle to oocyte growth and maturation, FIG. 1. Schematic illustration of diabetes induction, insulin treatment, and oocyte collection. Female mice received an injection of 190 mg/kg STZ on d 0. Four days later, blood glucose levels were determined via a commercial glucometer. Mice exhibiting blood glucose levels of at least 300 mg/dl were considered to be diabetic and then were administrated with 10 IU PMSG (d 4). Two days after PMSG, the ovaries were isolated, and cumulus-enclosed GV oocytes were collected (d 6). To retrieve ovulated oocytes, mice were injected with 10 IU hCG 2 d after PMSG. At 13.5 h after hCG administration, oocytes were collected from oviductal ampullae (d 7). this phenomenon implied a disturbance in the intrafollicular environment of diabetic mice.
Because oocytes with morphological abnormalities ( Fig. 2A ; black arrowheads) degenerate at high frequency, only those oocytes with a normal appearance ( Fig. 2A ; red arrowheads) were selected for further analysis.
Alteration of mitochondrial ultrastructure in oocytes from diabetic mice
To determine whether maternal diabetes has effects on the mitochondrial ultrastructure in oocytes, transmission electron microscopy (TEM) was performed on ovulated oocytes from control and diabetic mice.
Most mitochondria in control oocytes (Fig. 3A, B) contain clearly visible intact inner membrane, outer membrane, and a well-defined intermembrane space. In striking contrast, two structural aberrations were readily observed in mitochondria of diabetic oocytes: a narrowed intermembrane space (Fig. 3 , C and D) and rupture of the outer membrane with only the inner membrane observed (Fig. 3, C and E) . Quantitative analysis of a number of representative electron micrographs demonstrated that 68.6 Ϯ 14.3% of mitochondria in diabetic oocytes had structural abnormalities, which is significantly increased as compared with 15.7 Ϯ 4.3% observed in control oocyte (Fig. 3F) . In all, 15 oocytes from five control mice and 15 oocytes from five diabetic mice were used for quantification. In addition, the electron density of the matrix appears to be lower in the mitochondria of diabetic oocytes (Fig. 3, A and C) . These ultrastructural alterations suggest swelling of mitochondria, which in somatic cells is thought to herald mitochondrial-dependent apoptosis and degradation (23) . Together, TEM studies suggest deleterious effects of maternal diabetes on the mitochondrial structure in oocytes.
Increased mtDNA copy number during oocyte development in diabetic mice
An essential component of mitochondrial function is mtDNA (24) . To investigate whether maternal diabetes affects mtDNA content during oocyte development, we compared the mtDNA copy number in fully grown oocytes from control and diabetic mice. Quantitative realtime PCR was performed on single GV and MII oocytes (Fig. 4) . On average, control GV and MII oocytes possessed 228,000 (Ϯ 59,900) and 238,000 (Ϯ 93,100) mtDNA molecules, respectively, consistent with a previous report (25) . However, notably, the average mtDNA copy number in GV and MII oocytes from diabetic mice was significantly increased to 312,000 (Ϯ 92,400) and 312,000 (Ϯ 114,000) (P Ͻ 0.05), respectively, indicating that maternal diabetes either induces mitochondrial biogenesis or inhibits degradation in oocytes.
FIG. 3.
Altered mitochondrial ultrastructure in ovulated oocytes from diabetic mice. MII oocytes retrieved from control and diabetic mice were subjected to TEM, analysis and mitochondrial ultrastructure was compared. A, Representative electron micrographs of mitochondria from control oocytes; B, higher-magnification view of boxed region in A shows the clearly visible structure of inner membrane (IM) and outer membrane (OM) and a well-defined intermembrane space (IMS); C, representative electron micrograph of mitochondria from diabetic oocytes D and E, higher-magnification views of boxed regions in C shows mitochondrial ultrastructural aberrations, including narrowed intermembrane space (D) and rupture of outer membrane (E); F, quantification analyses of abnormal mitochondria in ovulated oocytes from control and diabetic mice. Data are presented as mean percentage of abnormal mitochondria Ϯ SD in each oocyte. *, P Ͻ 0.05 vs. control.
FIG. 4.
Distribution of mtDNA copy number in single GV and MII oocyte from control and diabetic mice. Quantitative real-time PCR was performed on single oocytes to determine the mtDNA copy number. For each box, the central bar represents the mean; upper and lower boundaries of boxes represent Ϯ SD, and vertical lines extend to the maximal and minimal values for each stage. The t test analyses of average mtDNA copy number between classes at each stage indicated that the differences were significant in all diabetic vs. control tests: *, P Ͻ 0.05.
Reduced function of mitochondria in ovulated oocytes from diabetic mice
Given the alterations in mitochondrial ultrastructure and mtDNA content, we asked whether mitochondrial function was altered in oocytes exposed to maternal diabetes. Recent studies strongly suggested that the mammalian mature oocyte displays a high ATP turnover and that the ATP consumed is supplied by mitochondria (26) . Therefore, by conducting microanalytical assays, we measured the levels of ATP and some TCA cycle metabolites in single ovulated oocytes from control and diabetic mice. All metabolites are expressed as millimoles per kilogram wet weight (Kw) based on the wet weight of 160 ng per oocyte (15) .
As shown in Fig. 5A , we found that the average ATP levels in diabetic oocytes were significantly decreased when compared with controls (3.03 Ϯ 0.94 mm/Kw, n ϭ30 vs. 3.91 Ϯ 0.42 mm/Kw control, n ϭ30). In addition, we noticed that the variation in ATP levels between oocytes from diabetic mice was considerably greater than that observed in oocytes from control mice (coefficient of variation ϭ 0.09 for control vs. 0.26 for diabetic), which may reflect the heterogeneous status of cytoplasmic maturation of oocytes from diabetic mice. Furthermore, the same oocytes were used to measure the TCA cycle metabolite content. As shown in Fig. 5 , B-D, we detected reduced levels of citrate (1.64 Ϯ 0.27 vs. 1.86 Ϯ 0.29 mm/Kw control, P Ͻ 0.05), aspartate (1.18 Ϯ 0.15 vs.
1.33 Ϯ 0.10 mm/Kw control, P Ͻ 0.05) as well as malate (0.41 Ϯ 0.13 vs. 0.57 Ϯ 0.09 mm/Kw control, P Ͻ 0.05) in ovulated oocytes from diabetic mice as compared with controls mice, implying inefficiency of TCA cycle metabolism. Together from these data (Figs. 3 and 5) and our previous results (9), we conclude that maternal diabetes results in the reduction of mitochondrial function in oocytes.
Maternal diabetes disrupts mitochondrial redistribution during oocyte maturation
Studies of several mammalian species have shown that mitochondria undergo stage-specific changes in distribution during oocyte maturation (13) . Such a spatial remodeling of mitochondria may allow maturing oocytes to cater to differing energy requirements and provide a means for environmental sensing (13) . To check whether maternal diabetes influences the spatial remodeling of mitochondria during oocyte maturation, we compared the mitochondrial distribution patterns between oocytes from control and diabetic mice.
As reported previously (27) , the apparent accumulation of mitochondria around the GV (Fig. 6Ai ) was observed in the majority of control GV oocytes (62 Ϯ 2%, n ϭ 54; Fig. 6C ), which we call the perinuclear distribution pattern. This distribution is considered the control immature pattern. With the completion of meiotic maturation, mitochondria display a polarized distribution pattern (Fig. 6Bi ) in 72 Ϯ 13% of MII arrested oocytes (n ϭ 62; Fig. 6D ), characterized by the enriched localization around the MII spindle. This pattern is considered the control mature pattern. A homogeneous distribution of mitochondria throughout the entire ooplasm can simultaneously be detected in 37 Ϯ 4% of GV oocytes (Fig. 6 , Aii and C) and 27 Ϯ 12% of MII oocytes (Fig. 6 , Bii and D) from control mice. This distribution is considered the intermediate step between immature and mature.
The distribution pattern of mitochondria during meiotic maturation was disrupted in oocytes from diabetic mice. As shown in Fig. 6 , C and D, one pronounced tendency is that the percentage of the perinuclear distribution pattern (GV, 43 Ϯ 16 vs. 62 Ϯ 2% control, P Ͻ 0.05) and polarized distribution pattern (MII, 34 Ϯ 6 vs. 72 Ϯ 13% control; P Ͻ 0.05) was decreased relative to control, whereas the proportion of the homogeneous distribution pattern was increased relative to controls (GV, 41 Ϯ 15 vs. 37 Ϯ 4% control, P Ͼ 0.05; MII, 47 Ϯ 6 vs. 27 Ϯ 12% control, P Ͻ 0.05). This observation indicates an insufficient or delayed translocation of mitochondria in oocytes from diabetic mice. Importantly, at both GV and MII stages, oocytes from diabetic mice displayed a much higher percentage of aggregating or clustering mitochon- Interestingly, we consistently detected chromosomal congression failure (abnormal alignment; Fig. 6E , lower panel, red arrows) in the MII oocytes from diabetic mice that display clustered mitochondria (83%; 10 of 12). This correlation strongly suggests that deficient chromosome alignment may be directly linked to abnormal mitochondrial distribution. In combination with previous reports showing the involvement of mitochondrial function in spindle assembly and genomic stability of germ cells (22, 28) , we extended our studies to examine spindle and chromosome organization during oocyte meiosis in STZ-induced diabetic mice.
Maternal diabetes induces spindle defects and chromosome misalignment during oocyte maturation
To test for possible effects of maternal diabetes on the organization of the spindle and chromatin during meiotic maturation, ovulated MII oocytes were immunolabeled with ␤-tubulin antibody to visualize the spindle and costained with TO-PRO to visualize chromosomes. By performing confocal scanning and quantitative analysis, we found that most control MII oocytes presented a typical barrel-shape spindle and wellaligned chromosomes on the metaphase plate (Fig. 7A) . Only 4.0 Ϯ 1.1 and 1.3 Ϯ 1.3% of oocytes displayed a disorganized spindle and chromosomes (n ϭ 147; Fig.  7B ), respectively. In contrast, a high frequency of spindle defects were observed in ovulated MII oocytes from diabetic mice (11.5 Ϯ 1.6%, n ϭ 148; Fig. 7B) , showing prominent extra asters, monopolar spindles, and diverse malformed spindles (Fig. 7A, arrows) . Concomitant with this, the percentage of chromosome misalignment was also significantly increased in oocytes from diabetic mice (9.1 Ϯ 2.1%, n ϭ 148; Fig. 7B ), characterized by the displacement of one or several chromosomes from equator (Fig. 7A, arrowheads) . These data suggest that maternal diabetes induces spindle defects and chromosome misalignment in oocytes. 
Increased incidence of aneuploidy in ovulated oocytes from diabetic mice
We postulated that spindle and chromosome disorganization during diabetic oocyte meiosis would act to generate aneuploid oocytes. To address this possibility, karyotypic status was analyzed in ovulated MII oocytes by chromosome spreading. As postulated, aneuploidy was observed in 18.9% of oocytes from diabetic mice compared with 4.4% of controls (Fig. 8, A and B, shows representative images of euploidy and hyperploidy, respectively; Fig. 8D ). In addition to the numerical abnormalities, we occasionally observed premature separation of sister chromatids in diabetic oocytes, where the two chromatids of the chromosome have prematurely separated at the centromere before rather than during anaphase II (Fig. 8C, arrows; Fig. 8D, 10.8 vs. 0.0% control). Ample data have shown that premature centromere separation represents a predisposition to chromosome missegregation (29) . These observations suggest that meiotic defects induced by maternal diabetes increase an incidence of aneuploidy in oocytes, which could lead to reproductive failure and congenital birth defects.
Akita genetic diabetic model shows reduced mitochondrial function and spindle defects and chromosome misalignment
To test whether mitochondrial dysfunction and meiotic defects in oocytes from STZ-induced diabetic mice were caused by STZ itself rather than maternal diabetes, we examined some of the key phenotypes in the Akita mouse model (see Materials and Methods). Ovulated MII oocytes were used for analysis, and similar results were obtained: 15.1% of oocytes (n ϭ 92) from Akita mice showed the abnormal morphological characteristics ( Fig.  2A, black arrowheads) , which was significantly higher than controls (7.4%, n ϭ 81; supplemental Fig. 1 , published as supplemental data on The Endocrine Society's Journals Online web site at http://mend.endojournals. org). The ATP content was markedly reduced in oocytes from Akita mice as compared with those from control mice (4.51 Ϯ 0.41 vs. 4.83 Ϯ 0.38 mm/Kw control, P Ͻ 0.05; supplemental Fig. 2 ). Confocal microscopy also demonstrated a significantly higher percentage of spindle defects and chromosome misalignment in Akita oocytes than in controls (spindle defects, 14.3 Ϯ 5.1%, n ϭ 45, vs. 7.5 Ϯ 3.2% control, n ϭ 40; chromosome misalignment, 11.4 Ϯ 1.7%, n ϭ 45, vs. 2.5 Ϯ 2.0% control, n ϭ 40; supplemental Fig. S3, A and B) .
FIG. 7.
Maternal diabetes induces spindle defects and chromosome misalignment in oocyte meiosis. A, Ovulated MII oocytes from control and diabetic mice were stained with ␤-tubulin antibody to visualize the spindle (green) and counterstained with TO-PRO to visualize chromosomes (red). MII oocytes from control mice present a typical barrel-shaped spindle and well-aligned chromosomes on the metaphase plate. In MII oocytes from diabetic mice, spindle defects (arrows) and chromosome misalignment (arrowheads) were readily observed. Representative confocal sections are shown. B, Quantification of ovulated MII oocytes with spindle defects and chromosome misalignment from control and diabetic mice. Data are expressed as mean percentage Ϯ SD from three independent experiments in which at least 150 oocytes were analyzed. *, P Ͻ 0.05 vs. controls. Scale bars, 20 m.
FIG. 8.
Chromosome spread of ovulated oocytes from control and diabetic mice. Metaphase spreads were stained with DAPI and examined using fluorescence microscopy. A-C, Representative negative fluorescence micrographs of oocytes from control mice with a normal haploid complement of 20 chromosomes (A), oocytes from diabetic mice with 21 chromosomes (B), oocytes from diabetic mice with premature separation of sister chromatids (PSSC) indicated by arrows (C); D, summary of an incidence of aneuploidy and PSSC in ovulated oocytes from control and diabetic mice.
Discussion
Mitochondria house the respiratory chain for the generation of cellular energy and are the site of essential biosynthetic pathways. Here, using TEM, we demonstrate swelling and even outer membrane rupture of mitochondria in ovulated oocytes from diabetic mice. These ultrastructural aberrations are indicative of an increase of mitochondrial membrane permeability, which is directly regulated by the Bcl-2 family of proteins (30) . Interestingly, we previously found that expression of Bax, a proapoptotic member of the Bcl-2 family, is increased in blastocyst embryos recovered from diabetic mice and that these changes correlate morphologically with increased DNA fragmentation (31) . Thus, these observations suggest the possibility that maternal transmission of oocyte mitochondria with structural abnormalities lead, at least in part, to high levels of apoptosis in preimplantation embryos in diabetic mice.
Variations in the ATP content have been suggested to significantly affect oocyte quality, embryonic development, and the implantation process (32, 33) . Here, we found that the content of ATP and TCA cycle metabolites are dramatically decreased in oocytes from diabetic mice. This observation indicates a functional decline of mitochondria in diabetic oocytes, which is likely related to their structural abnormalities. Nonetheless, we cannot exclude the possibility that maternal diabetes induces defective metabolism in cumulus cells, which may partly contribute to the diminished oocyte ATP. Moreover, it has been demonstrated that mitochondrial dysfunction in mouse oocytes results in preimplantation embryo arrest in vitro (34) . In addition, sublethal injury to murine oocyte mitochondria resulted in some aberrations in cytoplasmic patterning of the mitochondria (35) , and upon in vitro fertilization, these resultant embryos demonstrated increased miscarriages, growth retardation, and neural tube defects similar to that seen with diabetic embryopathy. Treatment of one-cell zygotes with protonophore carbonyl cyanide p-trifluoromethoxy-phenylhydrazone to disrupt mitochondrial function also markedly delayed the cleavage of early embryos (28) . Together with our findings, we propose that mitochondrial dysfunction in oocytes may contribute to the developmental retardation that has been reported in preimplantation embryos from diabetic mice (2, 4) .
The mtDNA content experiences drastic restriction and amplification during oogenesis. May-Panloup et al. (24) report that low mtDNA copy number is associated with oocyte incompetence, fertilization failure, and even ovarian insufficiency. Surprisingly, our data showed that average mtDNA copy number in oocytes from diabetic mice was significantly greater than that in control oocytes (Fig. 4) . It is worth noting that mtDNA copy number was also found to be increased in the oocytes from older women (36) . Such an increase in mitochondrial biogenesis was attributed to a compensatory phenomenon to guarantee sufficient ATP production in the event of either an increased demand or due to a respiratory chain dysfunction. It is also possible to explain this as a decrease in mitochondrial degradation or autophagy. Several recent studies have reported that autophagy is essential for successful transition from oocyte to embryo (37, 38) , and it is possible that diabetes and exposure to hyperglycemia may lead to abnormal levels of autophagy as seen in skeletal muscle (39) .
Immunofluorescence microscopy analysis revealed that maternal diabetes leads to the inadequate translocation of mitochondria during oocyte maturation, which is a marker of delayed cytoplasmic maturation (12) . Increased mitochondrial clustering was readily observed in oocytes from diabetic mice as compared with controls. Moreover, it is generally thought that mitochondrial spatial remodeling may be indicative of energy or ion requirement of various key events, such as GV breakdown and metaphase spindle formation (13) . Thereby, inadequate redistribution of mitochondria may be one of the important factors contributing to the maturation delay (9) and spindle/chromosome disorganization (Fig. 7) observed in diabetic oocytes. In support of this hypothesis, we found cooccurrence of chromosome congression failure and mitochondrial clustering in diabetic MII oocytes (Fig. 6E) . Interestingly, MII oocytes ovulated by nondiabetic aged mice also displayed a higher percentage of mitochondrial aggregates (40) and was suggested to be a cause of developmental retardation (41) . Together with increased mtDNA copy number, these observations support the notion that oocytes from young diabetic mice are, in a number of ways, analogous to aged oocytes from matched nondiabetic controls (42) .
Our cytological analysis revealed that maternal diabetes induces an increased frequency of meiotic spindle defects and chromosome misalignment in oocytes. Karyotypic analysis confirmed the increased aneuploidy rate in MII oocytes from diabetic mice. This is in line with a previous report showing a high frequency of chromosomal numerical anomalies in embryos from diabetic mice (43) and suggests that the embryonic aneuploidy is due, at least in part, to a meiotic defect in the oocyte. We note that Veselá et al. (44) did not observe a significant difference in the chromosomal constitution of MII oocytes between subdiabetic and control mice. However, this discrepancy may be caused by different severities of the diabetic state.
Mitochondrial dysfunction may provide the explanation for these meiotic defects in diabetic oocytes. First, low ATP and TCA cycle metabolite levels suggest reduced mitochondrial function. Chromatin condensation during meiosis is an ATP-dependent process. A recent study re-vealed that injury of mitochondria in MII oocytes reduces ATP content and disrupts the meiotic spindle (22, 45) . Notably, Pdha1-deficient (pyruvate dehydrogenase a1) mouse oocytes also experience inadequate ATP levels along with chromatin and microtubular abnormalities (21) . Oocytes from senescence-accelerated mice also demonstrated spindle defects and disturbances in chromosome alignment associated with mitochondrial dysfunction (28) . Second, abnormal distribution patterns suggest spatial dysfunction of mitochondria. As discussed above, our results indicate a direct link between chromosome congression and mitochondrial distribution in oocytes (Fig. 6E) . Most recently, association of mitochondria with spindle poles was found to facilitate spindle alignment in Schizosaccharomyces pombe (46) . Although it is likely that mitochondrial dysfunction plays a crucial roles in the meiotic defects in diabetic oocytes, we cannot rule out that other factors may also be involved in this process.
The mechanism and the extent to which maternal diabetes exerts its effect directly on the oocyte are not clear at this time. In the growing follicle, multiple layers of granulosa cells completely envelope the oocyte, and only the innermost layers are in direct contact with the oocyte via gap junctions. Moreover, oocytes carry out glycolysis poorly and require granulosa cell-provided products of glycolysis for their own development (47) . It is known that the type I diabetic mouse is characterized by hyperglycemia and hypoinsulinemia. Thus, it is possible that hyperglycemia may disturb the metabolism of granulosa cells, and such adverse effects are then transferred into oocytes. Alternatively or additionally, hypoinsulinemia could directly be a contributory factor, because the insulin signaling pathway has been reported to function in chromatin remodeling during oocyte growth (48) .
In conclusion, our results suggest that maternal diabetes results in oocyte defects that are transmitted to the embryo by two routes: first, meiotic spindle and chromatin defects, which may be caused by oocyte mitochondrial abnormalities, lead to embryonic aneuploidy; second, structural and functional abnormalities of oocyte mitochondria, through maternal transmission, provide the embryo with a dysfunctional complement of mitochondria that may be propagated during embryogenesis and fetal development. Mitochondrial dysfunction and meiotic defects in oocytes probably contribute to the reproductive problems experienced by type I diabetic mice as well as women. Our findings may also have clinical implications for the assessment of oocyte quality from diabetic women. For example, polarization microscopy (49) can be used to directly recognize those diabetic oocytes with abnormal spindles; noninvasive measures of ATP have been made in other tissue types, and therefore it may be possible to screen diabetic oocytes for ATP content to produce best-quality embryos; and finally, targeting drugs to improve mitochondrial function in oocytes may have therapeutic potential in treating reproductive failure of diabetic women.
Materials and Methods
All mouse studies were approved by the Animal Studies Committee at Washington University School of Medicine and conform to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health.
Generation of diabetic mice
To generate a diabetic model (Fig. 1) , female B6SJLF1 mice (age 20 -24 d) received a single injection of STZ at a dose of 190 mg/kg. Four days after injection, a tail-blood sample was measured for glucose concentrations via a Hemocue B glucose analyzer (Stockholm, Sweden). If glucose levels were greater than 300 mg/dl, the animal was selected for use as a diabetic model. A few age-matched control mice were also randomly selected.
Akita mice
Akita mice have an autosomal dominant mutation, resulting in hyperglycemia and notable pancreatic ␤-cell dysfunction (50) . All Akita mice (FVB.B6-Ins2Akita/MlnJ; The Jackson Laboratory, Bar Harbor, ME; stock no. 006867) had glucose checked at approximately 7-8 wk through a tail-blood sample. If glucose levels were more than 250 mg/dl, these mice were considered to have the mutation. Age-matched controls were FVB/N females with glucose levels of approximately 150 mg/dl.
Oocyte collection and culture
To collect fully grown GV oocytes (Fig. 1) , control and diabetic mice were primed with 10 IU pregnant mares serum gonadotropin (PMSG) by ip injection, and 48 h later, cumulusenclosed oocytes were obtained by manual rupturing of antral ovarian follicles.
To collect ovulated oocytes (Fig. 1 ), control and diabetic mice received an injection of 10 IU human chorionic gonadotropin (hCG) 2 d after PMSG priming. Oocytes were recovered from oviductal ampullae 13.5 h after hCG, and cumulus cells were removed by incubating briefly in 1 mg/ml hyaluronidase.
TEM
For ultrastructural analysis of mitochondria, oocytes were processed for TEM as described previously (51) . The morphometry of mitochondria ultrastructure was determined from electron micrographs at ϫ10,000 magnification. To quantify the abnormal mitochondria, for each oocyte, three different fields from two sections were counted in a blinded fashion. In all, 15 oocytes from five control mice and 15 oocytes from five diabetic mice were used for quantification, respectively.
Determination of mtDNA copy number by quantitative real-time PCR
The mtDNA extraction and quantitative real-time PCR procedure have been described previously (52) . Briefly, a single oocyte was loaded in a PCR tube with 10 l lysis buffer and was incubated at 55 C for 2 h. Proteinase K was heat inactivated at 95 C for 10 min, and then the samples were used directly for PCR analysis. Quantitative real-time PCR was performed using the ABI system and mouse mtDNA-specific primers: B6 forward, AACCTGGCACTGAGTCACCA, and B6 reverse, GG-GTCTGAGTGTATATATCATGAAGAGAAT.
To obtain the standard curve, PCR products amplified with B6 forward and B6 reverse primers were ligated into T-vector. Five 10-fold serial dilutions of purified plasmid standard DNA were used to generate the standard curve. Linear regression analysis of all standard curves for samples with copy number between 10 2 and 10 6 showed a correlation coefficient higher than 0.98. All measurements were performed in triplicate.
Metabolite microanalytic assays
Denuded oocytes were frozen on a glass slide by dipping in cold isopentane equilibrated with liquid nitrogen. After freezedrying overnight under vacuum at Ϫ35 C, the oocytes were extracted in nanoliter volume under oil. Separate assays were developed for each metabolite measured and were designed to link reactions ending with NAD/NADH or NADP/NADPH, which then were enzymatically amplified in a cycling reaction, and a byproduct of the amplification step was measured in a fluorometric assay. The detailed assay conditions have been described in Chi et al. (15) .
Immunofluorescence
For mitochondria staining, denuded oocytes were cultured in M2 medium containing 200 nM MitoTracker Red (Molecular Probes, Eugene, OR) for 10 min at 37 C. After washes, oocytes were fixed with 4% paraformaldehyde for 20 min and then treated with 0.2% Triton X-100 for 30 min. After the brief counterstaining with 4Ј,6Ј-diamidino-2-phenylindole (DAPI), samples were analyzed by fluorescence microscopy (Zeiss Axioskop, Gö ttingen, Germany).
For spindle and chromosome analysis, oocytes were fixed with 4% paraformaldehyde for 30 min and then permeabilized with 0.5% Triton X-100 for 20 min. After blocking in 1% BSA-supplemented PBS for 1 h, samples were incubated overnight at 4 C with fluorescein isothiocyanate-conjugated ␤-tubulin antibody (Sigma Chemical Co., St. Louis, MO; 1:100) to visualize the spindle. Chromosomes of oocytes were evaluated by costaining with 4 m To-Pro-3-iodide (Molecular Probes, Eugene, OR) for 5 min. Samples were examined under a laserscanning confocal microscope (TCS-SP2; Leica, Wetzlar, Germany).
Chromosome spread
Chromosome preparations for ovulated oocytes were as described previously (53) . In brief, oocytes were treated with 1% sodium citrate for 20 min, individually transferred to a glass slide, and then fixed in situ with several drops of three parts methanol to one part acetic acid. After air drying, the chromosomes were observed by fluorescence microscopy after staining with DAPI.
Statistical analysis
Data are presented as mean Ϯ SD, unless otherwise indicated. Statistical comparisons were made with Student's t test and ANOVA when appropriate. P Ͻ 0.05 was considered to be significant.
